PUTTAGUNTA SAILAJA (Chief Medical Officer) sold 40.4% of their position (3.37K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market sale worth $4.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2022ACC: 0001209191-22-059733
Officer· Chief Medical Officer
Since Dec 2021
-3.37K
Net shares
Net seller
$4.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.33K acquired · 11.70K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+8.33K
Price / share
—
Trade value
—
% of position
New position
12/1/2022
0.00→8.33K
Ordinary Shares
Direct
Shares
−3.37K
Price / share
$1.32
Trade value
$4.44K
% of position
40.4%
12/2/2022
8.33K→4.97K
Total
Net shares
+4.97K
Net value
-$4.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/1/2022 | A · Award | +8.33K | — | — | New position | 0.00 | 8.33K |
| Ordinary Shares Direct | 12/2/2022 | S · Sale | −3.37K | $1.32 | $4.44K | 40.4% | 8.33K | 4.97K |
| Total | +4.97K | -$4.44K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
8.33K shares
Shares
−8.33K
Strike price
Held after
25K
Exercisable
—
12/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares8.33K shares | 12/1/2022 | M · Option Exercise | −8.33K | — | 25K |